Soluble lipidated ligand agents for treating eye inflammation
US12060397B2 · kind B2 · utility
0Cited by
9References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 12, 2021 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | Feb 13, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2440/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application provides methods for preparing soluble lipidated ligand agents comprising a ligand entity and a lipid entity, and in some embodiments, provides relevant parameters of each of these components, thereby enabling appropriate selection of components to assemble active agents for any given target of interest.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.